Skip to Main Content

The Circulating Cell-free Genome Atlas Study

Principal Investigator

Jonathan Trent

Enrollment Status

Closed

Clinical Trial ID

Institutional Protocol # 20160980
National Clinical Trials Identifier NCT02889978

Clinical Trial Summary


Phase

N/A


Funding Agency/Sponsor

Industrial


Disease

Bone and Soft Tissue Cancers


Enrollment Eligibility

Inclusion Criteria for Non-Cancer Arm Participants:
- Age 20 years or older
- Able to provide a written informed consent
Exclusion Criteria for Non-Cancer Arm Participants:
- Known current or prior diagnosis of cancer except non-melanoma skin cancer
- Oral or IV corticosteroid use in past 14 days prior to blood draw
- Pregnancy (by self-report)
- Current febrile illness
- Acute exacerbation or flare of an inflammatory condition requiring escalation in
medical therapy within 14 days prior to blood draw.
- Recipient of organ transplant or prior non-autologous (allogeneic) bone marrow or stem
cell transplant
- Poor health status or unfit to tolerate blood draw
Inclusion Criteria for Cancer Arm Participants:
- Age 20 years or older
- Able to provide a written informed consent
Have either of the following:
A. Confirmed cancer diagnosis (any stage I-IV, as well as carcinoma in situ (CIS) within 90
days prior to or up to 42 days after study blood draw, based upon assessment of a
pathological specimen
OR
B. A high suspicion for a cancer diagnosis by clinical and/or radiological assessment, with
planned biopsy or surgical resection to establish a definitive diagnosis within 6 weeks (42
days) after study blood draw
Exclusion Criteria for Cancer Arm Participants:
- Known prior diagnosis of cancer except non-melanoma skin cancer
- Currently receiving, or ever received, any of the following therapies to treat their
current cancer: surgical management of the cancer beyond that required to establish
the cancer diagnosis; local, regional or systemic chemotherapy including
chemoembolization; targeted therapy, immunotherapy including cancer vaccines; hormone
therapy; or radiation therapy
- Pregnancy (by self-report)
- Current febrile illness
- Acute exacerbation or flare of an inflammatory condition requiring escalation in
medical therapy within 14 days prior to blood draw.
- Recipient of organ transplant or prior non-autologous (allogeneic) bone marrow or stem
cell transplant
- Poor health status or unfit to tolerate blood draw

Accepts Healthy Volunteers

Call 305-243-2647


Contact Information

Phone Number 305-243-2647
Get detailed information on ClinicalTrials.Gov